Ionis to hold second quarter 2025 financial results webcast
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology, and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Jim Cramer Highlights Microsoft's $4 Trillion Moment and AI-Driven Strength
Microsoft Corporation (NASDAQ:MSFT) is one of the stocks that Jim Cramer spoke about. During the episode, Cramer discussed the company's recently posted strong earnings. He said: 'What should it have been about? Well, how about Microsoft? How about Meta? Nope. They were overshadowed by the Fig-Man Carnival. It was all anyone talked about down here. Call me old-fashioned, but I really wanted the market today to be defined by those earnings reports from two tech titans. I'm talking about Microsoft, briefly a $4 trillion company today, before closing just below that level, and Meta at just under $2 trillion. I wanted these to be foundational… Pixabay/Public Domain Microsoft Corporation (NASDAQ:MSFT) provides software, cloud services, devices, and AI-driven tools across productivity, business applications, and personal computing. The company's major platforms include Microsoft 365, Azure, LinkedIn, Xbox, , and WGitHubindows. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Jim Cramer Shares His Take on TeraWulf
TeraWulf Inc. (NASDAQ:WULF) is one of the stocks that Jim Cramer spoke about. During the lightning round, a caller asked for Cramer's thoughts on the company, and he remarked: 'Well, again, I mean, I like the real, I'm a real deal guy. I got, I like the Bitcoin. I can, you know, I wish I could feel it. I like gold even more, but that's a whole 'nother kettle of gold.' Photo by Executium on Unsplash TeraWulf (NASDAQ:WULF) is a digital asset technology company that develops and operates bitcoin mining facilities and offers hosting services for third-party miners. When announcing its Q1 2025 results, Chief Executive Officer Paul Prager reiterated that the company is aiming to secure additional HPC customers with the goal of reaching between 200 and 250 megawatts of contracted HPC capacity by the end of 2026. The company reported that it remains on schedule to complete the deployment of its Core42 project within the year and has started the financing process required to move into the next stage of its HPC development. While we acknowledge the potential of WULF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Jim Cramer on Lam Research: 'Let it Come in And Then Do Some Buying'
Lam Research Corporation (NASDAQ:LRCX) is one of the stocks that Jim Cramer spoke about. When a caller asked about the company during the lightning round, Cramer replied: 'Lam Research had a great quarter. Don't believe anything else. I mean, I know the stock's rolling over because the chart's bad. I really liked it. I thought that Tim Archer did a terrific job. Let it come in and then do some buying.' Wichy/ Lam Research (NASDAQ:LRCX) provides advanced semiconductor processing equipment used in chip fabrication. The company specializes in deposition, etch, and cleaning technologies. During the July 22 episode, Cramer said, 'Don't be in a hurry' to buy the stock, as he commented: 'It would be best to accept that the food and drugs can have a couple of days in the sun, can't they? The old leaders pulled back a little, can't they? Don't be in a hurry to buy Lam Research or Applied Materials or KLA… not after we had Texas Instruments on tonight, and I wouldn't step in front of the falling knives that represent any of the meme stocks…' While we acknowledge the potential of LRCX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
